PTEN loss promotes oncogenic function of STMN1 via PI3K/AKT pathway in lung cancer
Abstract Among all cancer types, lung cancer has already become the leading cause of cancer-related death around the world. The molecular mechanism understanding this development is still needed to be improved to treat lung cancer. Stathmin (STMN1) was initially identified as a cytoplasmic protein p...
Main Authors: | Guangsu Xun, Wei Hu, Bing Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-07-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-93815-3 |
Similar Items
-
Specific gene expression signatures induced by the multiple oncogenic alterations that occur within the PTEN/PI3K/AKT pathway in lung cancer.
by: Carmela De Marco, et al.
Published: (2017-01-01) -
Dysregulation of PI3K/Akt/PTEN Pathway in Canine Mammary Tumor
by: Soo-Hyeon Kim, et al.
Published: (2021-07-01) -
Clinicopathological Research and Expression of PTEN/PI3K/Akt Signaling Pathway in Non-small Cell Lung Cancer
by: Hong SHU, et al.
Published: (2009-08-01) -
lncNALT knockdown ameliorates hypertensive retinopathy via PTEN/PI3K/AKT pathway
by: Haijun Kang, et al.
Published: (2022-12-01) -
MicroRNA‐4286 promotes cell proliferation, migration, and invasion via PTEN regulation of the PI3K/Akt pathway in non‐small cell lung cancer
by: Chunhua Ling, et al.
Published: (2019-07-01)